J. Yoshida, S. Koda, S. Nishida, T. Yoshida, K. Miyajima et al., Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan, Journal of Oncology Pharmacy Practice, vol.14, issue.1, pp.29-38, 2011.
DOI : 10.1007/s00420-007-0284-y

R. Schierl, A. Herwig, A. Pfaller, S. Groebmair, and E. Fischer, Surface contamination of antineoplastic drug vials: Comparison of unprotected and protected vials, American Journal of Health-System Pharmacy, vol.67, issue.6, pp.428-429, 2010.
DOI : 10.2146/ajhp080621

J. Bussières, C. Tanguay, K. Touzin, E. Langlois, and M. Lefebvre, Environmental Contamination with Hazardous Drugs in Quebec Hospitals, The Canadian Journal of Hospital Pharmacy, vol.65, issue.6, pp.428-435, 2012.
DOI : 10.4212/cjhp.v65i6.1190

D. Xl-merger, C. Tanguay, E. Langlois, M. Lefebvre, and J. Bussières, Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals, International Archives of Occupational and Environmental Health, vol.8, issue.1, pp.307-313, 2013.
DOI : 10.1080/15459624.2011.537510

M. Xli-berruyer, C. Tanguay, N. Caron, M. Lefebvre, and J. Bussières, Multicenter Study of Environmental Contamination with Antineoplastic Drugs in 36 Canadian Hospitals: A 2013 Follow-up Study, Journal of Occupational and Environmental Hygiene, vol.59, issue.3, pp.87-94, 2015.
DOI : 10.1093/annhyg/mes061

A. Janes, C. Tanguay, N. Caron, and J. Bussières, Environmental Contamination with Cyclophosphamide, Ifosfamide, and Methotrexate: A Study of 51 Canadian Centres, The Canadian Journal of Hospital Pharmacy, vol.68, issue.4, pp.279-289, 2015.
DOI : 10.4212/cjhp.v68i4.1467

. Vidal, Disponible en ligne sur : https, 2016.

R. Dorr, V. Hoff, D. Ct, U. Appleton, and &. Lange, Part III: Drug monographs Cancer chemotherapy handbook, Selon Micromedex. [consulté le 06.07.2016]. xlv Product Information. Cytoxan®, cyclophosphamide, pp.129-975, 1994.

R. Xlvii-nelson, L. Allen, and P. Creaven, Pharmacokinetics of divided-dose ifosfamide, Clinical Pharmacology & Therapeutics, vol.19, issue.3, pp.365-370, 1976.
DOI : 10.1002/cpt1976193365

N. Institute, . Safety, . Health, . Niosh, and . Alert, Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings, 2004.

B. Valanis, W. Vollmer, and K. Labuhn, Acute symptoms associated with antineoplastic drug handling among nurses, Cancer Nursing, vol.16, issue.4, pp.288-295, 1993.
DOI : 10.1097/00002820-199308000-00005

G. Dranitsaris, M. Johnston, and S. Poirier, Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature, Journal of Oncology Pharmacy Practice, vol.8, issue.2, pp.69-78, 2005.
DOI : 10.1111/j.0272-4332.2004.00433.x

T. Connor, C. Lawson, and M. Polovich, Reproductive Health Risks Associated With Occupational Exposures to Antineoplastic Drugs in Health Care Settings, Journal of Occupational and Environmental Medicine, vol.56, issue.9, pp.901-910, 2014.
DOI : 10.1097/JOM.0000000000000249

A. El-ebiary, A. Abuelfadl, and N. Sarhan, Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists, Journal of Applied Toxicology, vol.48, issue.3, pp.196-201, 2013.
DOI : 10.1539/joh.48.517

J. Bussiè-res, C. Tanguay, and K. Touzin, Environmental contamination with hazardous drugs in Quebec hospitals, Can J Hosp Pharm, vol.65, pp.428-435, 2012.

D. Merger, C. Tanguay, and E. Langlois, Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals, International Archives of Occupational and Environmental Health, vol.8, issue.1, pp.307-313, 2013.
DOI : 10.1080/15459624.2011.537510

M. Berruyer, C. Tanguay, and N. Caron, Multicenter Study of Environmental Contamination with Antineoplastic Drugs in 36 Canadian Hospitals: A 2013 Follow-up Study, Journal of Occupational and Environmental Hygiene, vol.59, issue.3, pp.87-94, 2015.
DOI : 10.1093/annhyg/mes061

A. Janes, C. Tanguay, and N. Caron, Environmental Contamination with Cyclophosphamide, Ifosfamide, and Methotrexate: A Study of 51 Canadian Centres, The Canadian Journal of Hospital Pharmacy, vol.68, issue.4, pp.279-289, 2015.
DOI : 10.4212/cjhp.v68i4.1467

R. Dorr, V. Hoff, and D. , Part III: Drug monographs, Cancer chemotherapy handbook, pp.129-975, 1994.

R. Nelson, L. Allen, and P. Creaven, Pharmacokinetics of divided-dose ifosfamide, Clinical Pharmacology & Therapeutics, vol.19, issue.3, pp.365-370, 1976.
DOI : 10.1002/cpt1976193365

R. Diasio and H. Be, Clinical Pharmacology of 5-Fluorouracil, Clinical Pharmacokinetics, vol.16, issue.4, pp.215-237, 1989.
DOI : 10.2165/00003088-198916040-00002

S. Ndaw, F. Denis, and P. Marsan, Biological monitoring of occupational exposure to 5-fluorouracil: Urinary ??-fluoro-??-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel, Journal of Chromatography B, vol.878, issue.27, pp.2630-2634, 2010.
DOI : 10.1016/j.jchromb.2010.02.011

S. Maeda, K. Miyawaki, and S. Matsumoto, Evaluation of Environmental Contaminations and Occupational Exposures Involved in Preparation of Chemotherapeutic Drugs, YAKUGAKU ZASSHI, vol.130, issue.6, pp.903-910, 2010.
DOI : 10.1248/yakushi.130.903

C. Sottani, B. Porro, and M. Imbriani, Occupational exposure to antineoplastic drugs in four Italian health care settings, Toxicology Letters, vol.213, issue.1, pp.107-115, 2012.
DOI : 10.1016/j.toxlet.2011.03.028

C. Hon, K. Teschke, and H. Shen, Antineoplastic drug contamination in the urine of Canadian healthcare workers, International Archives of Occupational and Environmental Health, vol.26, issue.3, pp.933-941, 2015.
DOI : 10.1093/mutage/geq102

C. Ji, L. Sykes, and C. Paul, Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake, Revista Panamericana de Salud P??blica, vol.32, issue.4, pp.307-315, 2012.
DOI : 10.1590/S1020-49892012001000010

B. Teo, P. Loh, and W. Wong, Spot Urine Estimations Are Equivalent to 24-Hour Urine Assessments of Urine Protein Excretion for Predicting Clinical Outcomes, International Journal of Nephrology, vol.3, issue.2, supplement 1, p.156484, 2015.
DOI : 10.1053/j.ajkd.2014.01.002

J. Woods, M. Martin, and B. Leroux, Validity of spot urine samples as a surrogate measure of 24-hour porphyrin excretion rates. Evaluation of diurnal variations in porphyrin, mercury, and creatinine concentrations among subjects with very low occupational mercury exposure, J Occup Environ Med, vol.40, pp.1090-1101, 1998.

L. Sabatini, A. Barbieri, and V. Lodi, Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings, Med Lav, vol.103, pp.394-401, 2012.

J. Yoshida, S. Koda, and S. Nishida, Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital, Ann Occup Hyg, vol.57, pp.251-260, 2013.